EGR1 and metabolic dysfunction-associated steatotic liver disease: A study showed that the transcriptional regulation of EGR1 could help to regulate steatosis in the liver; however, in patients with IR, the expression of EGR1 was shown to be downregulated, therefore promoting the development of steatosis and MASLD [50].